× Want to know more about the Kunena Project? See how the open source philosophy drives our community, follow our development on GitHub, and how you can participate to make Kunena even better.

regulatory process," Gottlieb warned. The FDA has

More
1 month 1 week ago #226977 by Davidssasw
biosimilars by further strengthening our pipeline and widening the availability of approved treatments for cancer patients across the US. In randomized, controlled clinical trials, the per-patient incidences of NCI-CTC Grade 3-4 neutropenia and of febrile neutropenia were higher in patients receiving trastuzumab products in combination with myelosuppressive chemotherapy as compared to those who received chemotherapy alone.
iglesiaepp.hn/index.php/kunena/5-general...sion/316682-k#316673
The incidence of septic death was similar among patients who received trastuzumab and those who did not Sales of electronic-cigarettes could be halted if companies don't stop marketing the devices to youth, U.S. Food and Drug Administration Commissioner Dr. Scott Gottlieb warned. He's said he's horrified at the recent rise in teen use of the
poligonoindustrial.sanisidro.es/forums/t...aclofen-over-natten/
e-cigarettes and that FDA efforts to get companies to voluntarily eliminate candy-flavored products and aggressive marketing have had little effect, NBC News reported. "I'll tell you this. If the youth use continues to rise, and we see significant increases in use in 2019, on top of the dramatic rise in 2018, the entire category will face an existential threat," he said Friday. "It will be game over for these products until they can successfully traverse the
smartartbox.com/challenge

Please Anmelden or Create an account to join the conversation.